1. The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
   Xiaochun Wang et al, 2020, Oncotarget CrossRef
2. EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
   Hanxiao Xu et al, 2019, Frontiers in Oncology CrossRef
3. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma
   Xiang Lu Ji et al, 2019, Aging CrossRef